(Q40585386)

21 September 2017

Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2. (English)

1 reference

21 September 2017

6

Vincent Bours

0 references

Marie-Paule Merville

5

object named as

Marie-Paule Merville

0 references

author name string

Valérie Benoit

1

1 reference

21 September 2017

Biserka Relic

2

1 reference

21 September 2017

Xavier de Leval Xd

3

1 reference

21 September 2017

Alain Chariot

4

1 reference

21 September 2017

Marie-Paule Merville

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

21 September 2017

1 reference

21 September 2017

23

1 reference

21 September 2017

8

1 reference

21 September 2017

1631-1635

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207295

21 September 2017

0 references

cites work

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Regulation of cyclooxygenase-2 pathway by HER2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207295

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207295

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference